Robert Leboyer Email & Phone Number
Senior Biotechnology Analyst @ NOBLE Capital Markets
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Robert Leboyer Location
- New York, NY, US
Robert Leboyer Work
- Senior Biotechnology Analyst @ (April 2021 - Present)
- Managing Director, Biotechnology Analyst @ Ladenburg Thalmann (May 2019 - March 2021)
- Managing Director, Senior Biotechnology Analyst @ (January 2018 - April 2019)
- Biotechnology Analyst @ (July 2015 - December 2017)
- Equity Research Analyst - Biotechnology @ (August 2014 - June 2015)
- Senior Investment Banker @ (February 2009 - August 2013)
- Sr. Analyst @ Medivalu (July 2007 - February 2009)
- Chief Financial Officer @ SignPath Pharmaceuticals, Inc. (March 2007 - January 2009)
- Senior Biotechnology Analyst @ Ehrenkrantz King Nussbaum (July 2003 - November 2005)
- Sr. Biotechnology Analyst @ Leerink Swann (January 1999 - January 2001)
- Senior Biotechnology Analyst @ (June 1994 - March 1998)
- Vice President @ (March 1992 - June 1994)
Robert Leboyer Education
- Columbia Business School
MBA (Finance and Operations Management)
1990-1991 - Tulane University
BS (Economics)
1981-1985
Robert Leboyer Skills
- Financial Modeling
- Venture Capital
- Valuation
- Due Diligence
- Mergers & Acquisitions
- Corporate Finance
- Equity Research
- Lifesciences
- Private Equity
- Licensing
- Investments
- Equities
- Financial Services
- Accounting
- Private Placements
- Corporate Development
- Start-ups
- Entrepreneurship
- M&A experience
- IPO
- Finance
- Business Strategy
- Biotechnology
- Market Analysis
- Investment Banking
- Capital Markets
- Hedge Funds
- Strategic Planning
- Strategy
- Management
- Investor Relations
- Emerging Markets
- LBO
- Growth Capital
- Restructuring
- Financial Analysis
- Sales
- News
- Selling
- Networking
- Budgets
- Offering
- Hearings
- Patent Litigation
- Economics
- Series 7
- Business Development
- Meetings
- S 1
- Cash Flow
- Executive Positions
- Consulting
- Healthcare
- Syndications
- Pharmaceutical Industry
- Negotiation
- Capital
- HR Management
- New York
- Audio Conferencing
- FDA
- Temporary Placement
- Insurance
- Reports
- First Call
- Capitalization
- Outlook
- Secondary Offerings
- Viewpoints
- Capital Allocation
- Fundamental Analysis
- Financials
- Bridge
- Stock Picking
- Mergers and Acquisitions
- Patents
- Drug Delivery
- Biotechnology Industry
- Boston
- Start Ups
- Scientific
- Acting
- Contractual Agreements
- Materials
- Intellectual Property
- Roadshows
- Public Speaking
- Acquisitions
- Dinners
- Regulations
- Term Sheets
- Seminars
- Clinical Outcomes
- Neurology
- Market
- Clinical Trials
- Writing
- Medicine
- Strategies
- Conferences
- Research
- Operations Management
- Pipelines
- Stocks
- Marketing
- Short
- Google Groups
- PIPEs
- In Licensing
- Cancer
- Boutique
- Client Accounts
- Securities
- Universe
- Conceptual Modeling
- Farms
Robert Leboyer Summary
- Robert Leboyer, based in New York, NY, US, is currently a Senior Biotechnology Analyst at NOBLE Capital Markets. Robert Leboyer brings experience from previous roles at Ladenburg Thalmann, ROTH Capital Partners, Aegis Capital and Maxim Group. Robert Leboyer holds a 1990 - 1991 MBA in Finance and Operations Management @ Columbia Business School. With a robust skill set that includes Financial Modeling, Venture Capital, Valuation, Due Diligence, Mergers & Acquisitions and more. Robert Leboyer has 5 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Robert Leboyer?
Find contact details for 700 million professionals.
Top NOBLE Capital Markets Employees
Manny Geronimos
Managing Director
United States
Margaret Burke
VP trading
Boston, MA, US
Joachim Bader
Managing Director
Florida, United States
Christopher Patches
Director - IT and Digital Operations
Gainesville, FL, US
Danica Chapman
Director of Business Development
Miami, FL, US
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co